These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 7824835)
21. [Clinical significance of serum soluble interleukin-2 receptor (sIL-2R) determination in patients with rheumatoid arthritis]. Takemura M; Seishima M; Noma A; Kasai C; Satoh M; Morita T; Takeuchi S Rinsho Byori; 1996 Jun; 44(6):564-8. PubMed ID: 8752735 [TBL] [Abstract][Full Text] [Related]
22. Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis. Suenaga Y; Yasuda M; Yamamoto M; Nonaka S; Wada T; Shiokawa S; Nobunaga M Clin Rheumatol; 1998; 17(4):311-7. PubMed ID: 9776115 [TBL] [Abstract][Full Text] [Related]
23. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Cope AP; Aderka D; Doherty M; Engelmann H; Gibbons D; Jones AC; Brennan FM; Maini RN; Wallach D; Feldmann M Arthritis Rheum; 1992 Oct; 35(10):1160-9. PubMed ID: 1329774 [TBL] [Abstract][Full Text] [Related]
25. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Hein GE; Köhler M; Oelzner P; Stein G; Franke S Rheumatol Int; 2005 Dec; 26(2):137-41. PubMed ID: 15580352 [TBL] [Abstract][Full Text] [Related]
26. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs. Crilly A; Madhok R; Watson J; Capell HA Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995 [TBL] [Abstract][Full Text] [Related]
27. [Soluble IL-2 receptor levels in rheumatic diseases]. Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465 [TBL] [Abstract][Full Text] [Related]
28. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy. Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819 [TBL] [Abstract][Full Text] [Related]
29. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment. Boiardi L; Macchioni P; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I Clin Exp Rheumatol; 1994; 12(4):357-62. PubMed ID: 7955597 [TBL] [Abstract][Full Text] [Related]
30. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis. Wolf RE; Brelsford WG; Hall VC; Adams SB J Rheumatol; 1992 Apr; 19(4):524-8. PubMed ID: 1593571 [TBL] [Abstract][Full Text] [Related]
31. [Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction?]. Karrer U; Aeschlimann A; Fassbender K; Vogt P; Müller W Schweiz Med Wochenschr; 1992 Feb; 122(7):233-6. PubMed ID: 1539125 [TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis. Silverman ED; Laxer RM; Nelson DL; Rubin LA J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944 [TBL] [Abstract][Full Text] [Related]
33. Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptor. Jensen HS; Tvede N; Diamant M; Mogensen HH; Hansen MB; Thomsen BS; Pedersen PB; Bendtzen K Scand J Rheumatol; 1991; 20(2):83-90. PubMed ID: 1903212 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. Symons JA; McDowell TL; di Giovine FS; Wood NC; Capper SJ; Duff GW Lymphokine Res; 1989; 8(3):365-72. PubMed ID: 2789325 [TBL] [Abstract][Full Text] [Related]
35. Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? Wood NC; Symons JA; Duff GW J Autoimmun; 1988 Aug; 1(4):353-61. PubMed ID: 3266993 [TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of detection of soluble interleukin 2 receptor alpha chain in the assessment of rheumatoid arthritis disease activity]. Xu JJ; Wang Y; Sun H; Jia RL; Zhang XW; Meng Y; Ren LL; Sun XL Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):975-980. PubMed ID: 30562767 [TBL] [Abstract][Full Text] [Related]
37. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis]. Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592 [TBL] [Abstract][Full Text] [Related]
38. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity. Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852 [TBL] [Abstract][Full Text] [Related]